SPOTLIGHT: Lilly settles 900 more Zyprexa claims


Eli Lilly has settled some 900 lawsuits over its antipsychotic drug Zyprexa, including five set to go to trial next month, leaving about 1,100 claims unsettled. Many of the plaintiffs alleged that Lilly downplayed the drug's side effects, including weight gain and elevated blood sugar. The company has set aside $1.2 billion to cover the claims. Report | Report

Suggested Articles

More than a year after J&J and Bayer pulled the plug on Xarelto in patients after a rare valve replacement, the pair are still seeking answers.

Novartis hopes to leverage its existing presence in the hematology community to achieve a successful launch of Adakveo.

AstraZeneca's Farxiga is touting its heart failure data in patients with or without diabetes, but results in non-diabetics looks particularly strong.